Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
D 79.91 1.77% 1.39
GKOS closed up 1.77 percent on Friday, June 11, 2021, on 37 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical GKOS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Weak + Overbought Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.77%
Bollinger Band Squeeze Range Contraction 1.77%
Upper Bollinger Band Walk Strength 1.77%
Older End-of-Day Signals for GKOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Glaukos Corporation Description

Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.


Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmic Ophthalmology Drainage Glaucoma Blindness Vision Implant Incision Treatment Of Glaucoma Cornea Eye Surgery Intraocular Pressure

Is GKOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 98.88
52 Week Low 35.65
Average Volume 346,445
200-Day Moving Average 73.49
50-Day Moving Average 81.80
20-Day Moving Average 75.29
10-Day Moving Average 75.88
Average True Range 2.47
ADX 23.92
+DI 25.87
-DI 23.29
Chandelier Exit (Long, 3 ATRs) 72.58
Chandelier Exit (Short, 3 ATRs) 78.88
Upper Bollinger Bands 79.14
Lower Bollinger Band 71.44
Percent B (%b) 1.1
BandWidth 10.22
MACD Line -1.06
MACD Signal Line -2.17
MACD Histogram 1.1098
Fundamentals Value
Market Cap 3.59 Billion
Num Shares 45 Million
EPS 0.37
Price-to-Earnings (P/E) Ratio 215.97
Price-to-Sales 15.31
Price-to-Book 4.82
PEG Ratio 1.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 82.18
Resistance 3 (R3) 81.95 80.97 81.80
Resistance 2 (R2) 80.97 80.39 81.08 81.67
Resistance 1 (R1) 80.44 80.04 80.71 80.67 81.55
Pivot Point 79.46 79.46 79.59 79.57 79.46
Support 1 (S1) 78.93 78.88 79.20 79.16 78.27
Support 2 (S2) 77.95 78.53 78.06 78.15
Support 3 (S3) 77.42 77.95 78.02
Support 4 (S4) 77.65